BeOne Medicines(DE:49BA)
€368.00+6.00 (+1.66%)
DE:49BA
BeOne Medicines ownership
€368.00
At close:+6.00 (+1.66%)
BeOne Medicines (49BA) Ownership - Who Owns BeOne Medicines?
4 Followers
BeOne Medicines (49BA) Ownership Overview
- 64.39% Insiders
- 12.11% Mutual Funds
- 1.21% Other Institutional Investors
- 1.43% ETFs
- 20.86% Public Companies and Individual Investors
The ownership structure of BeOne Medicines (DE:49BA) stock is a mix of institutional, retail, and individual investors. Approximately 14.75% of the company’s stock is owned by Institutional Investors, 64.39% is owned by Insiders, and 20.86% is owned by Public Companies and Individual Investors.
The ownership structure of BeOne Medicines (DE:49BA) stock is a mix of institutional, retail, and individual investors. Approximately 14.75% of the company’s stock is owned by Institutional Investors, 64.39% is owned by Insiders, and 20.86% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Nov 09, 2026 | Titus B. Ball | $632,273 | |
| Sep 02, 2026 | Titus B. Ball | $46,974 | |
| Aug 04, 2026 | Aaron Rosenberg | $361,805 | |
| Aug 02, 2026 | Henry Chan Lee | $337,932 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2025 | Blackstone Inc. | €1,580,723 | |
| Dec 31, 2025 | Driehaus Capital Management Llc | €7,052,341 | |
| Dec 31, 2025 | Woodline Partners Lp | €20,350,712 | |
| Dec 31, 2025 | Primecap Management Co | €1,513,150,313 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| John Oyler | 47,362,982 | Insider | 43.14% | 19,340,815,789 |
| Xiaodong Wang | 9,566,326 | Insider | 8.71% | 3,906,437,921 |
| Baker Bros. Advisors Lp | 8,981,441 | Insider | 8.18% | 3,667,598,377 |
| Felix Baker | 8,801,567 | Institution | 8.02% | 3,594,146,289 |
| Theofanis Kolokotrones | 5,007,931 | Institution | 4.56% | 2,045,003,648 |
| New Perspective Fund | 2,663,960 | Institution | 2.43% | 1,087,836,058 |
| Vanguard Chester Funds | 2,347,622 | Institution | 2.14% | 958,658,487 |
| Lai Wang | 2,282,969 | Insider | 2.08% | 932,257,240 |
| Xiaobin Wu | 1,286,449 | Insider | 1.17% | 525,325,308 |
| Primecap Odyssey Funds | 1,231,174 | Institution | 1.12% | 502,753,596 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| New Perspective Fund | 2,663,960 | Institution | 2.43% | 1,087,836,058 |
| Vanguard Chester Funds | 2,347,622 | Institution | 2.14% | 958,658,487 |
| Primecap Odyssey Funds | 1,231,174 | Institution | 1.12% | 502,753,596 |
| Vanguard Horizon Funds | 1,182,071 | Institution | 1.08% | 482,702,239 |
| Fidelity Mt. Vernon Street Trust | 941,694 | Institution | 0.86% | 384,543,570 |
| New Economy Fund | 875,269 | Institution | 0.80% | 357,418,722 |
| Eupac Fund | 700,821 | Institution | 0.64% | 286,182,358 |
| New World Fund Inc | 677,287 | Institution | 0.62% | 276,572,178 |
| Europacific Growth Fund | 649,336 | Institution | 0.59% | 265,158,304 |
| American Funds Global Insight Fund | 374,007 | Institution | 0.34% | 152,726,880 |
FAQ
Who Owns BeOne Medicines (DE:49BA)?
According to the latest TipRanks data, approximately 14.75% of the company's stock is held by institutional investors, 64.39% is held by insiders, and 20.86% is held by public companies and individual investors.
What percentage of BeOne Medicines (DE:49BA) stock is held by institutional investors?
According to the latest TipRanks data, approximately 14.75% of BeOne Medicines (DE:49BA) stock is held by institutional investors: 12.11% by mutual funds, 1.43% by ETFs and 1.21% by other institutional investors.
What percentage of BeOne Medicines (DE:49BA) stock is held by retail investors?
According to the latest TipRanks data, approximately 20.86% of BeOne Medicines (DE:49BA) stock is held by public companies and individual investors.
Who owns the most shares of BeOne Medicines (DE:49BA)?
JOHN OYLER owns the most shares of BeOne Medicines (DE:49BA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
